The critical role of interleukin-23 in spondyloarthropathy.
about
Impact of inflammation on the osteoblast in rheumatic diseasesSolving the puzzle of autoimmunity: critical questionsUpdate on ankylosing spondylitis: current concepts in pathogenesis.Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic ArthritisIL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patientsObservations on Chlamydia trachomatis and other microbes in reactive arthritis.Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review.Vitamin D and spondyloarthritis.The IL-23-IL-17 axis in inflammatory arthritis.Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.An overview of investigational new drugs for treating ankylosing spondylitis.HLA-B27 Anterior Uveitis: Immunology and Immunopathology.Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent.Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis.Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities.Therapies in ankylosing spondylitis-from clinical trials to clinical practice
P2860
Q26829246-793C1D63-FB40-4D1D-AA3E-65E6264F4C13Q28084677-14404660-3D3D-4085-B38A-C1C58EFCDF80Q34450732-30839D7D-B63A-470A-BC6D-EFF8C521A9A9Q35645174-2F959E28-1B76-4326-83EB-C31A10CE1007Q35667354-40D9CFA0-20A1-4238-97AD-C9DE132B2687Q36611562-AAB1C5DE-17D5-4F1F-BCF4-923909B0E784Q37844357-64B28749-ACBB-4548-B8B7-B2223A85DFE5Q38201788-24D6C689-EE52-4FA5-960F-C2B49F12822DQ38262855-B2AD0EB0-82A1-4B6B-ABC1-C34F3815532DQ38439641-A16711C6-D8E5-41AC-A4D2-9DAE4685BD18Q38593977-8C4205D7-4216-40BB-BA46-E44C5E7832A6Q38631462-79734DF1-1F98-43BB-8B67-1105863AA1FAQ38849274-C8B07823-C21D-4D6E-BA5E-3091AEB84024Q41895311-43B92BF5-06E3-45CB-809C-27382A356A69Q47944184-B09150FB-0EB3-45F2-AC65-F7D602206264Q53244572-DBF28C65-E9D1-4FA9-AD7C-E6ED76A72A3DQ55339808-45EC359B-7C21-4FE5-800F-DB07EDD4396EQ55512008-96B266F7-1328-4AF4-8A32-53F395B472DDQ59125383-F1C95C96-A79C-45AF-A1A4-74A9EA519AFA
P2860
The critical role of interleukin-23 in spondyloarthropathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The critical role of interleukin-23 in spondyloarthropathy.
@en
type
label
The critical role of interleukin-23 in spondyloarthropathy.
@en
prefLabel
The critical role of interleukin-23 in spondyloarthropathy.
@en
P2093
P1433
P1476
The critical role of interleukin-23 in spondyloarthropathy.
@en
P2093
Christopher D Buckley
Daniel J Cua
Jonathan P Sherlock
P356
10.1016/J.MOLIMM.2013.06.010
P577
2013-08-01T00:00:00Z